Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

Olorunfemi A. Oshagbemi, Frits M. E. Franssen, Dionne C. W. Braeken, Yvonne Henskens, Emiel F. M. Wouters, Anke-Hilse Maitland-van der Zee, Andrea M. Burden, Frank de Vries*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1191-1199
Number of pages9
JournalPharmacoepidemiology and Drug Safety
Volume27
Issue number11
DOIs
Publication statusPublished - Nov 2018

Keywords

  • chronic obstructive pulmonary disease
  • eosinophils
  • exacerbations
  • inhaled corticosteroids
  • pharmacoepidemiology
  • OBSTRUCTIVE PULMONARY-DISEASE
  • PRACTICE RESEARCH DATALINK
  • CLINICAL-PRACTICE
  • COMORBIDITIES
  • COUNT
  • PREVENTION
  • PNEUMONIA
  • STABILITY
  • BIOMARKER
  • MARKERS

Cite this